| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |